Discover and read the best of Twitter Threads about #hba1c
Most recents (10)
1a) Welcome to a live-tweeted, #accredited #tweetorial from @nationallipid #NLA23 in #Atlanta on advances in #hyperlipidemia management #LLT. Our expert returning faculty is Pam R. Taub, MD @PamTaubMD #cardiologist from @UCSDHealth 
1b) Dr. Taub is a clinician/scientist and is a frequent contributor to our #accredited programs. She is the founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center at #UCSD.
#FOAMed #cardiotwitter @MedTweetorials #MedEd #lipids
#FOAMed #cardiotwitter @MedTweetorials #MedEd #lipids
2) This program is supported by an educational grant from Esperion Therapeutics & is intended for #HCPs. Statement of accreditation & faculty disclosures at cardiometabolic-ce.com/disclosures/. Earn 0.75 hr 🆓CE/#CME by following this 🧵!
Should people be concerned with blood glucose concentrations if they don’t have prediabetes or diabetes?
1/10
#glucose #health #biohack #science #metabolism #cgms #hba1c #sugarspikes
1/10
#glucose #health #biohack #science #metabolism #cgms #hba1c #sugarspikes
For context, the relationship between LDL-cholesterol concentration and coronary heart disease risk appears linear across the entire physiological range
What about glucose?
2/10
What about glucose?
2/10
For glucose, it might depend how it’s measured:
STANDARDISED TESTS (reflect underlying physiology)
-Fasting [glucose]
-2-h [glucose] post-OGTT
FREE-LIVING MEASURES (reflect underlying physiology x acute behaviour)
-HbA1c
-CGMS variables
What do the data show?
3/10
STANDARDISED TESTS (reflect underlying physiology)
-Fasting [glucose]
-2-h [glucose] post-OGTT
FREE-LIVING MEASURES (reflect underlying physiology x acute behaviour)
-HbA1c
-CGMS variables
What do the data show?
3/10
1) Welcome to our #accredited #tweetorial on clinical trial results and emerging data for treatment of Diabetes and CKD #DM in #CKD. I am Brian Rifkin MD, @brian_rifkin, from the Hattiesburg Clinic. #Nephtwitter #Medtwitter #FOAMed
2) This #accredited #tweetorial series on #kidneydisease #CKD is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US- or UK-based HCPs. Accreditation statement & faculty disclosures at ckd-ce.com/disclosures/.
3) This activity is accredited for #physicians #physicianassociates #nurses #NPs #pharmacists. Prior programs in this series, still eligible for CE/#CME, can be accessed at ckd-ce.com. FOLLOW US to learn from expert faculty!
1a) Welcome to one of our favorite events on the @academiccme #accredited #tweetorial feeds: a takeover of our programming from @GoggleDocs! The focus of this tweetorial is data from #ADA2022 on #SGLT2i beyond cardiac disease. Our expert author is @GoggleDocs' @drpatrickholmes.
1b) Check out our other #ADA2022 recap #tweetorial by new @GoggleDocs family member @Ines_VFonseca who focused on the cardiac data presented: ckd-ce.com/dkd13_ada22a/
2) This program is #accredited for CE/#CME #physicians #physicianassociates #nurses #pharmacists #nursepractitioners & is supported by an educational grant from the Boehringer Ingelheim Pharmaceuticals Inc and Eli Lilly Company. It is intended for healthcare professionals.
1) Welcome to our new #accredited #tweetorial which is Part 2 of a 2-part "highlights" program on new #SGLT2i & #DKD data presented at @ERAkidney #ERA22. #Physicians #nurses #pharmacists #PAs and #NPs can all earn 0.5h CE/#CME by following this 🧵!
2a) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in #Nephrology. Our expert author is Dr. Clara GarcĂa Carro (@ClaraGCarro) from San Carlos Clinical Hospital (Madrid, Spain).
2b) Be sure to check out the first half of this #ERA22 recap from my colleague @shbermejo, and get MORE 🆓CE/#CME at ckd-ce.com/dkd12_ERA22a/. Join me in following @ckd_ce for the BEST in #cardiorenal education delivered entirely by #tweetorial!
1) Welcome to a new #accredited #tweetorial, Prevention and Management of Heart Failure in T2 Diabetes: The Diabetologist’s Perspective! Our expert author is Melanie J Davies CBE FMedSci @profmjdavies, Prof of Diabetes Medicine, U Leicester, Leicester Diabetes Unit @LDC_Tweets
2) This program is intended for #healthcare professionals and is accredited by @academiccme for 0.75h CE/#CME credit for #physicians #physicianassistants #nurses #nursepractitioners #pharmacists 🇺🇸🇨🇦🇬🇧🇪🇺. FOLLOW US for #cardiometabolic education from expert authors!
3) @cardiomet_CE is supported by educational grants from AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly Company, and Chiesi. See archived programs still available for credit at cardiometabolic-ce.com. Disclosures at cardiometabolic-ce.com/disclosures/
1/ #COVID-19 et #diabete : une contamination #SARScov2 peut-elle être un élément déclencheur ?
Très long (vraiment très long) #thread 🧵 ⤵️
Très long (vraiment très long) #thread 🧵 ⤵️
“Doctor, what should be my targets for Hba1c, Fasting and Post meal (PP) glucose?”
Many of our friends with Diabetes have this question. I will try to explain in the thread below.
#Diabetes #GlycemicTargets #HbA1c (1/n)
Many of our friends with Diabetes have this question. I will try to explain in the thread below.
#Diabetes #GlycemicTargets #HbA1c (1/n)
HbA1c should be done at least 2 times a year if goals are met and glucose control is stable,
Done more often if goals not met or there is change in the medicines.
A1c goal for many non pregnant adults is < 7% without any significant hypoglycaemia.
#Diabetes #HbA1c (2/n)
Done more often if goals not met or there is change in the medicines.
A1c goal for many non pregnant adults is < 7% without any significant hypoglycaemia.
#Diabetes #HbA1c (2/n)
Tighter HbA1c goals ( less than 7%) may be considered in some.
Less stringent goals (less than 8%) may be appropriate in pts with limited life expectancy or side effect of drugs.
Individualisation of glycemic targets is a must. It’s not a one size fits all criteria.
(3/n)
Less stringent goals (less than 8%) may be appropriate in pts with limited life expectancy or side effect of drugs.
Individualisation of glycemic targets is a must. It’s not a one size fits all criteria.
(3/n)
#Omnipod #DASH's had a user centric approach for the PDM design. The average #A1c of Omnipod users is 8.1% - Dr Thomas Danne
#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs
#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs
Omnipod #DASH is coming to Europe, soon in Austria, Belgium, France, Germany, Switzerland. Does that mean it will replace #Omnipod EROS?
#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs
investor.insulet.com/news-releases/…
#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs
investor.insulet.com/news-releases/…
#Omnipod #DASH a adopté une approche centrée sur l'utilisateur pour la conception du PDM. L' #HbA1c moyenne des utilisateurs d'Omnipod est de 8,1% - Dr Thomas Danne
#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs
#dedoc° #dedocvoices #EASD2020 #EASD
@EASDnews #NothingAboutUsWithoutUs
New strategy to treat #T1D: Simplici-T1 trail ⤵️
"subcutaneous #insulin is not enough" - Dr Carmen Valcare, on the activation of #glucokinase by #TTP399 improving #BG management.
Results: ⬇️ #TIR, #BG control, and #A1c
#dedoc° #dedocvoices #EASD2020 #EASD @EASDnews
"subcutaneous #insulin is not enough" - Dr Carmen Valcare, on the activation of #glucokinase by #TTP399 improving #BG management.
Results: ⬇️ #TIR, #BG control, and #A1c
#dedoc° #dedocvoices #EASD2020 #EASD @EASDnews
Nouvelle stratégie pour traiter le #DT1 : Simplici-T1
"L'insuline sous-cutanée n'est pas suffisante" - Dr Carmen Valcare, sur l'activation de la #glucokinase par le #TTP399 améliorant la gestion de la #BG
Résultats : ⬇️#TIR, #glycémie et #Hba1c
#dedoc° #dedocvoices #EASD
"L'insuline sous-cutanée n'est pas suffisante" - Dr Carmen Valcare, sur l'activation de la #glucokinase par le #TTP399 améliorant la gestion de la #BG
Résultats : ⬇️#TIR, #glycémie et #Hba1c
#dedoc° #dedocvoices #EASD
